More than 200 product liability cases claiming Zantac and its generic forms caused people to develop cancer were filed in Delaware Superior Court over the course of several days.

The complaints are signed by one of three Delaware legal teams, each of which named as defendants some combination of GlaxoSmithKline, Boehringer Ingelheim, Pfizer, Sanofi and Patheon Manufacturing Services. All were filed roughly between Aug. 23 and 26.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]